openPR Logo
Press release

Deadline on August 17th coming up in Lawsuit for Investors in Ocugen, Inc. (NASDAQ: OCGN)

07-21-2021 02:46 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A Deadline is coming up on August 17, 2021 in the lawsuit for certain investors in Ocugen, Inc. (NASDAQ: OCGN).

A Deadline is coming up on August 17, 2021 in the lawsuit for certain investors in Ocugen, Inc. (NASDAQ: OCGN).

A deadline is coming up on August 17, 2021 in the lawsuit filed for certain investors of Ocugen, Inc. (NASDAQ: OCGN) over alleged securities laws violations by Ocugen, Inc.

Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and there are strict and short deadlines running. Deadline: August 17, 2021. NASDAQ: OCGN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Eastern District of Pennsylvania the plaintiff alleges on behalf of purchasers of Ocugen, Inc. (NASDAQ: OCGN)) common shares between February 2, 2021 and June 10, 2021, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between February 2, 2021 and June 10, 2021, Ocugen, Inc made materially false and/or misleading statements and/or failed to disclose that the information submitted to the U.S. Food and Drug Administration ("FDA") was insufficient to support an Emergency Use Authorization ("EUA"), that Ocugen, Inc would not file an EUA with the FDA, and that as a result of the foregoing, the Company's financial statements, as well as Defendants' statements about Ocugen's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

Those who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and should contact the Shareholders Foundation.
About Shareholders Foundation, Inc.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deadline on August 17th coming up in Lawsuit for Investors in Ocugen, Inc. (NASDAQ: OCGN) here

News-ID: 2333226 • Views: 559

More Releases from Shareholders Foundation

Investigation announced for Investors in NYSE: RKT shares over possible Wrongdoi …
Certain directors of Rocket Companies, Inc are under investigation over possible breaches of fiduciary duties. Investors who are current long term investors in Rocket Companies, Inc. (NYSE: RKT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for investors in NYSE: RKT stocks follows a lawsuit filed against Rocket Companies, Inc. over alleged securities laws violations.
Investigation announced for Investors in Golden Nugget Online Gaming, Inc. (NASD …
An investigation was announced concerning the takeover of Golden Nugget Online Gaming, Inc. Investors who purchased shares of Golden Nugget Online Gaming, Inc. (NASDAQ: GNOG) and currently hold any of those NASDAQ: GNOG shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain officers and directors of Golden Nugget Online Gaming, Inc. breached their fiduciary
Investigation announced for Long-Term Investors in Virgin Galactic Holdings, Inc …
Certain directors of Virgin Galactic Holdings, Inc are under investigation concerning potential breaches of fiduciary duties. Investors who are current long term investors in Virgin Galactic Holdings, Inc. (NYSE: SPCE) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: SPCE stocks follows a lawsuit filed against Virgin Galactic Holdings,
Investigation announced for Investors in Kansas City Southern (NYSE: KSU) over T …
An investigation was announced concerning whether the takeover of Kansas City Southern is unfair to NYSE: KSU stockholders. Investors who purchased shares of Kansas City Southern (NYSE: KSU) and currently hold any of those NYSE: KSU shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain officers and directors of Kansas City Southern breached their

All 5 Releases


More Releases for Ocugen

COVID-19 Impact on Retinitis Pigmentosa Treatment & Management Market Overview a …
Retinitis Pigmentosa Treatment & Management Market is expected to grow significantly over next few years and generate considerable market for Retinitis Pigmentosa Treatment & Management. Market Report Expert has recently published a research report titled, “Retinitis Pigmentosa Treatment & Management Market Outlook and Statistics, 2020-2026". The report has been prepared by experienced and knowledgeable market analysts, researchers, market experts, and key option leaders within Retinitis Pigmentosa Treatment & Management market. It
Retinitis Pigmentosa (RP) Market 2025 : Ocugen, Inc., ReGenX Biosciences, LLC, S …
Global Retinitis Pigmentosa (RP) Market: Snapshot Retinitis pigmentosa, is a condition where patients typically loses ability to see at night in young years, side vision in middle age, and focal vision in later in his/her life due to relentless loss of cone photoreceptor cells. Proportions of retinal capacity, for example, the electroretinogram, demonstrate that photoreceptor capacity is decreased normally quite before symptomic night visual impairment, visual-field scotomas, or diminished visual sharpness
Retinitis Pigmentosa (RP) Market | Amarantus BioScience Holdings, Inc., Ocugen, …
Global Retinitis Pigmentosa (RP) Market: Snapshot Retinitis pigmentosa, in which patients usually lose night vision in teenage years, side vision in middle age, and central vision in later life because of steady loss of cone photoreceptor cells and rod. Measures of retinal function, such as the electroretinogram, indicate that photoreceptor function is reduced usually several years before visual-field scotomas, symptomic night blindness, or reduced visual acuity arise. Get Sample Copy of
Retinitis Pigmentosa (RP) Market | Amarantus BioScience Holdings, Inc., Ocugen, …
Global Retinitis Pigmentosa (RP) Market: Snapshot Retinitis pigmentosa, in which patients usually lose night vision in teenage years, side vision in middle age, and central vision in later life because of steady loss of cone photoreceptor cells and rod. Measures of retinal function, such as the electroretinogram, indicate that photoreceptor function is reduced usually several years before visual-field scotomas, symptomic night blindness, or reduced visual acuity arise. Get Brochure of the
Choroidal Neovascularization Therapeutics Pipeline Analysis 2018 | Graybug Visio …
Choroidal neovascularization is a type of medical condition in which new blood vessels are formed from choroid and extend into the subretinal space, or subretinal pigment epithelium, or a combination of both. Download the sample report @ https://www.pharmaproff.com/request-sample/1122 The disease can be symptomatized by a painless loss of vision, paracentral or central scotoma, and metamorphopsia. Choroidal neovascularization can be diagnosed by indocyanine green angiography, spectral domain optical coherence tomography, and fluorescein angiography.
Retinitis Pigmentosa (RP) Market Estimated to Flourish at by 2025 | Amarantus Bi …
Global Retinitis Pigmentosa (RP) Market: Snapshot Retinitis pigmentosa, in which patients usually lose night vision in teenage years, side vision in middle age, and central vision in later life because of steady loss of cone photoreceptor cells and rod. Measures of retinal function, such as the electroretinogram, indicate that photoreceptor function is reduced usually several years before visual-field scotomas, symptomic night blindness, or reduced visual acuity arise. Get Brochure of the